Domestic companies challenge inhaler market being monopolized by foreign ones

A series of domestic pharmaceutical companies have given prior notices to enter the inhaler market whose product dependency is mostly high on multinational companies.

Inhalers are usually launched by a small number of pharmaceutical companies – they are mostly multinational ones – due to the difficulty of developing them. 

According to the industry on the 23^rd, companies such as Daewon Pharm ...